Altered synapses in a Drosophila model of Alzheimer's disease
Open Access
- 1 January 2014
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 7 (3) , 373-385
Abstract
Alzheimer’s disease (AD) is an age-related neurodegenerative disease characterized by memory loss and decreased synaptic function. Advances in transgenic animal models of AD have facilitated our understanding of this disorder, and have aided in the development, speed and efficiency of testing potential therapeutics. Recently, we have described the characterization of a novel model of AD in the fruit fly, Drosophila melanogaster, where we expressed the human AD-associated proteins APP and BACE in the central nervous system of the fly. Here we describe synaptic defects in the larval neuromuscular junction (NMJ) in this model. Our results indicate that expression of human APP and BACE at the larval NMJ leads to defective larval locomotion behavior, decreased presynaptic connections, altered mitochondrial localization in presynaptic motor neurons and decreased postsynaptic protein levels. Treating larvae expressing APP and BACE with the γ-secretase inhibitor L-685,458 suppresses the behavioral defects as well as the pre- and postsynaptic defects. We suggest that this model will be useful to assess and model the synaptic dysfunction normally associated with AD, and will also serve as a powerful in vivo tool for rapid testing of potential therapeutics for AD.Keywords
This publication has 75 references indexed in Scilit:
- Proteolytic processing of Alzheimer’s β‐amyloid precursor proteinJournal of Neurochemistry, 2011
- Mitochondrial matrix Ca 2 + as an intrinsic signal regulating mitochondrial motility in axonsProceedings of the National Academy of Sciences, 2011
- Early deficits in synaptic mitochondria in an Alzheimer's disease mouse modelProceedings of the National Academy of Sciences, 2010
- Pharmacological Analysis of Drosophila melanogaster γ-Secretase with Respect to Differential Proteolysis of Notch and APPMolecular Pharmacology, 2010
- Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and DiseaseNeuron, 2010
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- Distinctive roles of different β‐amyloid 42 aggregates in modulation of synaptic functionsThe FASEB Journal, 2009
- A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1Journal of Biological Chemistry, 2008
- Spine-Type-Specific Recruitment of Newly Synthesized AMPA Receptors with LearningScience, 2008
- Oxidative damage in Alzheimer'sNature, 1996